• Glenmark secures UK MHRA approval for anti-malarial medication pharmaceutical-technology
    July 06, 2017
    Glenmark Pharmaceuticals Europe (Glenmark) has secured final approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Maloff Protect, its range of atovaquone / proguanil film-coated tablets.
PharmaSources Customer Service